Increased levels of NRF2 suppressed the endogenous ROS level in cancer stem cells (CSCs) compared with noncancer stem cells, suggesting the enrichment of stemness phenotypes [69,70,71,72]. The gene discussed is NFE2L2; the disease is cancer.